These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 25323232
1. Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H. Eur Respir J; 2015 Feb; 45(2):463-72. PubMed ID: 25323232 [Abstract] [Full Text] [Related]
2. Low-dose corticosteroid treatment in septic shock: a propensity-matching study. Funk D, Doucette S, Pisipati A, Dodek P, Marshall JC, Kumar A, Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Crit Care Med; 2014 Nov; 42(11):2333-41. PubMed ID: 25072758 [Abstract] [Full Text] [Related]
3. Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study. Tagami T, Matsui H, Fushimi K, Yasunaga H. Clin Infect Dis; 2015 Aug 01; 61(3):385-92. PubMed ID: 25882302 [Abstract] [Full Text] [Related]
4. Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study. Ceccato A, Russo A, Barbeta E, Oscanoa P, Tiseo G, Gabarrus A, Di Giannatale P, Nogas S, Cilloniz C, Menichetti F, Ferrer M, Niederman M, Falcone M, Torres A. Crit Care; 2021 Dec 16; 25(1):432. PubMed ID: 34915895 [Abstract] [Full Text] [Related]
5. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality. Cilli A, Erdem H, Karakurt Z, Turkan H, Yazicioglu-Mocin O, Adiguzel N, Gungor G, Bilge U, Tasci C, Yilmaz G, Oncul O, Dogan-Celik A, Erdemli O, Oztoprak N, Samur AA, Tomak Y, Inan A, Karaboga B, Tok D, Temur S, Oksuz H, Senturk O, Buyukkocak U, Yilmaz-Karadag F, Ozcengiz D, Karakas A, Savasci U, Ozgen-Alpaydın A, Kilic E, Elaldi N, Bilgic H. J Crit Care; 2013 Dec 16; 28(6):975-9. PubMed ID: 24075301 [Abstract] [Full Text] [Related]
6. Effects of systemic steroids in patients with severe community-acquired pneumonia. Garcia-Vidal C, Calbo E, Pascual V, Ferrer C, Quintana S, Garau J. Eur Respir J; 2007 Nov 16; 30(5):951-6. PubMed ID: 17690125 [Abstract] [Full Text] [Related]
7. Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis. Wu WF, Fang Q, He GJ. Am J Emerg Med; 2018 Feb 16; 36(2):179-184. PubMed ID: 28756034 [Abstract] [Full Text] [Related]
8. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation. Sakamoto Y, Yamauchi Y, Yasunaga H, Takeshima H, Hasegawa W, Jo T, Matsui H, Fushimi K, Nagase T. Respir Investig; 2017 Jan 16; 55(1):39-44. PubMed ID: 28012492 [Abstract] [Full Text] [Related]
9. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Polverino E, Cillóniz C, Dambrava P, Gabarrús A, Ferrer M, Agustí C, Prina E, Montull B, Menendez R, Niederman MS, Torres A. Respirology; 2013 Feb 16; 18(2):263-71. PubMed ID: 23134361 [Abstract] [Full Text] [Related]
10. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study. Ferrer M, Torres A, Martínez R, Ramírez P, Polverino E, Montull B, Sialer S, Niederman MS, Agusti A, Menéndez R. Respirology; 2014 Aug 16; 19(6):929-35. PubMed ID: 24909304 [Abstract] [Full Text] [Related]
11. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Génin R, Yvin JL. Eur Respir J; 2004 Nov 16; 24(5):779-85. PubMed ID: 15516672 [Abstract] [Full Text] [Related]
12. The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis. Paul M, Nielsen AD, Gafter-Gvili A, Tacconelli E, Andreassen S, Almanasreh N, Goldberg E, Cauda R, Frank U, Leibovici L. Eur Respir J; 2007 Sep 16; 30(3):525-31. PubMed ID: 17537772 [Abstract] [Full Text] [Related]
13. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C. JAMA; 2015 Feb 17; 313(7):677-86. PubMed ID: 25688779 [Abstract] [Full Text] [Related]
15. Sivelestat sodium and mortality in pneumonia patients requiring mechanical ventilation: propensity score analysis of a Japanese nationwide database. Kishimoto M, Yamana H, Inoue S, Noda T, Myojin T, Matsui H, Yasunaga H, Kawaguchi M, Imamura T. J Anesth; 2017 Jun 17; 31(3):405-412. PubMed ID: 28243749 [Abstract] [Full Text] [Related]
16. Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis. Huang J, Guo J, Li H, Huang W, Zhang T. Medicine (Baltimore); 2019 Mar 17; 98(13):e14636. PubMed ID: 30921179 [Abstract] [Full Text] [Related]
17. Prophylactic Antibiotics May Improve Outcome in Patients With Severe Burns Requiring Mechanical Ventilation: Propensity Score Analysis of a Japanese Nationwide Database. Tagami T, Matsui H, Fushimi K, Yasunaga H. Clin Infect Dis; 2016 Jan 01; 62(1):60-6. PubMed ID: 26405146 [Abstract] [Full Text] [Related]
20. Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia. Cangemi R, Falcone M, Taliani G, Calvieri C, Tiseo G, Romiti GF, Bertazzoni G, Farcomeni A, Violi F, SIXTUS Study Group. Ann Am Thorac Soc; 2019 Jan 01; 16(1):91-98. PubMed ID: 30188173 [Abstract] [Full Text] [Related] Page: [Next] [New Search]